Prophylactic Use of Negative Pressure Wound Therapy After Cesarean Delivery

Cost-effectiveness analysis alongside a pilot study of prophylactic negative pressure wound therapy

“…A previous pilot study reported some evidence of clinical effectiveness of prophylactic NPWT in obese women following caesarean section, however, that study used a weaker retrospective cohort design and did not evaluate cost-effectiveness [32]. A previous decision-analytic model of prophylactic NPWT following caesarean section concluded that prophylactic NPWT was not cost-effective [15]. That study considered only financial costs, which were also higher for NPWT in our study, and evaluated NPWT for all patients.…”

“…One previous study constructed a decision-analytic model of prophylactic NPWT following caesarean section and concluded that it was not cost-effective, however that study was not limited to overweight patients and did not consider quality of life (QoL) [15]. In this study, our aim was to evaluate whether NPWT is cost-effective compared to standard care for the prevention of SSIs in obese women undergoing elective caesarean section.…”

Closed incision negative pressure therapy: international multidisciplinary consensus recommendations

“…The remaining 40 publications were literature reviews including meta‐analyses, editorials, research articles or experimental model descriptions. Three articles were solely devoted to a health economic analysis , and three articles describe study protocols of future studies . A majority of the 100 publications reported data based on one manufacturer's system: n = 91, KCI, an Acelity company, San Antonio, TX, USA; n = 8, Smith and Nephew, plc, London, UK; n = 1, Daewoong Pharmaceutical, Co, Ltd., Seoul, South Korea.…”

“…Treatment costs are an important issue in patient care. To date, three studies examined the cost of ciNPT use and compared SSO rates and cost savings of ciNPT to routine incision care. Lewis et al concluded that ciNPT may be a cost‐effective treatment for closed laparotomy incisions following removal of gynaecological cancers if it reduces SSO rates .…”

The Betadine trial - antiseptic wound irrigation prior to skin closure at caesarean section to prevent surgical site infection: A randomised controlled trial

“…Extensive efforts have been made to reduce SSI after CS. These include the use of pre‐operative prophylactic intravenous antibiotics, the use of antiseptic solutions for the cleansing of skin, pre‐ and postoperative vaginal cleaning with an antiseptic solution and the use of negative pressure wound dressing …”